Second-generation compound for the modulation of utrophin in the therapy of DMD

Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin. There is currently no cure for DMD although various promising approaches are progressing through human clinical trials. By pharmacologically modulating the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiraud, Simon, Squire, Sarah E., Edwards, Benjamin, Chen, Huijia, Burns, David T., Shah, Nandini, Babbs, Arran, Davies, Stephen G., Wynne, Graham M., Russell, Angela J., Elsey, David, Wilson, Francis X., Tinsley, Jon M., Davies, Kay E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492389/
https://www.ncbi.nlm.nih.gov/pubmed/25935002
http://dx.doi.org/10.1093/hmg/ddv154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492389/
https://www.ncbi.nlm.nih.gov/pubmed/25935002
http://dx.doi.org/10.1093/hmg/ddv154

Ejemplares similares